An Investor’s Stress Test: How NHSU Rules Are Driving European Companies Away
Ukraine’s healthcare reimbursement rules are raising concerns among European investors, as private laboratory provider Synevo reports that nearly 700,000 tests were not recognized. Unequal treatment of private and state-run providers threatens fair competition, undermines investor confidence, and risks complicating Ukraine’s EU integration efforts.
We haven't written up this one. Kyiv Post has the full story — the link below goes straight to it.
